⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Coenzyme Q10 (CoQ10)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-29 — Dietary CoQ10 Ameliorates Age‐Related Megakaryocyte Dysfunction via COPS3‐Mediated Activation of Autophagy: Aged-mouse study (Aging Cell): dietary CoQ10 rescued age-related megakaryocyte dysfunction and platelet hyperreactivity via COPS3-mediated activation of autophagy — adds a specific molecular mechanism but remains preclinical with no human hemostasis outcome. [animal-model] (novelty: 3)
- 2026-10-01 — Dietary CoQ10 Ameliorates Age-Related Megakaryocyte Dysfunction via COPS3-Mediated Activation of Autophagy.: Aged-mouse study: dietary CoQ10 reduced age-related megakaryocyte dysfunction and platelet hyperreactivity, with mechanism traced to COPS3-mediated activation of autophagy — preclinical pathway detail, no human hemostasis outcome. [animal-model] (novelty: 3)
- 2026-09-25 — The Interplay of Metabolic Dysfunction, Neuroinflammation, and Mitochondrial Dysfunction in Balance Impairment: Insights from Type 2 Diabetes Mellitus and Alzheimer’s Disease.: Narrative review on balance impairment in T2DM and Alzheimer’s lists mitochondrial antioxidants (CoQ10 among them) as candidate interventions against a shared metabolic–neuroinflammatory–mitochondrial cycle — conceptual mention, no CoQ10-specific outcome data. [mechanism-plausible] (novelty: 3)
- 2026-09-15 — Antioxidant Interventions on Muscle Function and Mass in Aging-Related Muscle Decline: A Systematic Review of Preclinical and Clinical Evidence.: Referenced within a systematic review of antioxidant interventions for aging-related muscle decline; CoQ10-specific clinical evidence remained heterogeneous and underpowered, with strength/power endpoints more responsive than muscle mass. [human-rct] (novelty: 3)
- 2026-09-20 — Modulating Ubiquinone Biosynthesis Rescues Mitochondrial Dysfunction by Genetic Interaction in a Phosphatidylethanolamine (PE)-Deficient Disease Model.: C. elegans study: modulating ubiquinone (CoQ) biosynthesis rescued lifespan and mitochondrial defects in a PSD-1/PE-deficient disease model, positioning CoQ as an ETC retrograde-signaling lever rather than a direct human outcome for supplemental CoQ10. [animal-model] (novelty: 3)
- 2026-09-11 — Mitochondrial homeostasis in musculoskeletal diseases: From pathogenic mechanisms to precision therapies.: Musculoskeletal mitochondrial-homeostasis review references CoQ10 within the antioxidant/ETC-support arm of a precision therapy landscape but foregrounds mitochondria-targeted analogs (MitoQ/SkQ1) — parent CoQ10 remains without direct OP/OA/RA outcome data. [mechanism-plausible] (novelty: 3)
- 2026-08-05 — Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in Humans: Indirectly relevant: a new vascular-aging RCT continues to evaluate the mitochondria-targeted MitoQ analog rather than parent CoQ10, so age-related endothelial outcome data for CoQ10 itself remains absent. [mechanism-plausible] (novelty: 3)
- 2026-08-12 — The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults: Indirectly relevant: the Mito-Frail trial evaluates MitoQ (mitochondria-targeted CoQ10 derivative) rather than conventional CoQ10, underscoring that CoQ10 outcome data in frailty populations still comes via targeted analogs, not the parent molecule. [mechanism-plausible] (novelty: 3)
Open questions
Related
Contributing findings
Dietary CoQ10 Ameliorates Age-Related Megakaryocyte Dysfunction via COPS3-Mediated Activation of Autophagy.
01-oct-2026
novelty 3
per-area 3
strengthens
Design and physicochemical characterization of spray-dried microcapsules encapsulating o/w emulsion-based drug combinations.
30-sep-2026
novelty 2
per-area 2
strengthens
Dietary CoQ10 Ameliorates Age‐Related Megakaryocyte Dysfunction via COPS3‐Mediated Activation of Autophagy
29-sep-2026
novelty 3
per-area 3
strengthens
The Interplay of Metabolic Dysfunction, Neuroinflammation, and Mitochondrial Dysfunction in Balance Impairment: Insights from Type 2 Diabetes Mellitus and Alzheimer's Disease.
25-sep-2026
novelty 3
per-area 3
strengthens
Mitochondrial-Targeted Phytochemicals in Reproductive Aging: Mechanisms and Translational Potential.
25-sep-2026
novelty 2
per-area 2
strengthens
Modulating Ubiquinone Biosynthesis Rescues Mitochondrial Dysfunction by Genetic Interaction in a Phosphatidylethanolamine (PE)-Deficient Disease Model.
20-sep-2026
novelty 3
per-area 3
strengthens
Antioxidant Interventions on Muscle Function and Mass in Aging-Related Muscle Decline: A Systematic Review of Preclinical and Clinical Evidence.
15-sep-2026
novelty 3
per-area 3
strengthens
Mitochondrial homeostasis in musculoskeletal diseases: From pathogenic mechanisms to precision therapies.
11-sep-2026
novelty 3
per-area 3
strengthens
Causal Effect of Coenzyme Q10 Nutrition and Cognitive Dysfunction in the Metabolic Storm (Hyperglycemia and Sarcopenia) and Brain-derived Neurotrophic Factor
21-aug-2026
novelty 2
per-area 2
mentions
MItochondrial Intervention for Resilience in Older Adults With Coenzyme Q10
19-aug-2026
novelty 2
per-area 2
introduces
The Effects of Quercefit® and Ubiqsome™ in Mitigating Inflammation and Promoting Metabolic Health
12-aug-2026
novelty 2
per-area 2
mentions
The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults
12-aug-2026
novelty 3
per-area 3
strengthens
Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in Humans
05-aug-2026
novelty 3
per-area 3
strengthens
Food Supplement for Longevity
22-jun-2026
novelty 2
per-area 2
mentions